21 November 2023 in Acta Poloniae Pharmaceutica - Drug Research
Betulin is natural pentacyclic triterpenoids lupane-structure, which shows a wide range of biological activity, including possibly hypoglycemic effects. Diabetes mellitus is a metabolic disease, accompanied by chronic hyperglycemia caused by absolute or relative insulin deficiency. The main effective drug in the treatment of type 1 diabetes is insulin injections. In the case of type 2 diabetes, it is an adjuvant therapy. To purpose of this study was to show hypoglycemic action of betulin in a model of experimentally induced diabetes in rats. For the induction of diabetes, alloxan at a dose of 170 mg/kg, i.p. was used. The hypoglycemic effect of betulin was evaluated using doses of 50 and 100 mg/kg/day for 30 days. The activity of glucose metabolism enzymes: liver glycogen phosphorylase, hexokinase and liver and skeletal muscle phosphofructokinase in rats, glucose-6-phosphate dehydrogenase (DG-6-P) of the liver was also evaluated. Betulin in a dose-dependent manner normalized of glycemia, increased the basal insulin concentration in the blood serum, increased the activity of carbohydrate metabolizing enzymes and on the gene expression profile of enzymes involved in carbohydrate metabolism. Betulin also significant improved the morphology of the pancreas. In particular, there was an increase in the area of the islands, their diameter, an increase in the number of β cells in the composition of the islands. We conclude that betulin has hypoglycemic properties, improving glycemia and carbohydrate metabolizing enzymes and pancreatic morphology.
28 April 2023 in Acta Poloniae Pharmaceutica - Drug Research
1 January 2024 in Acta Poloniae Pharmaceutica - Drug Research
The multifunctional characteristics of Phallus impudicus extract encourage to conduct research for its potential use in medical applications. Diabetes mellitus is a metabolic disease, accompanied by chronic hyperglycemia caused by absolute or relative insulin deficiency. To purpose of this study was to show the potential role of Phallus impudicus extract in accelerating of wound healing in diabetes rats. For the induction of diabetes, streptozotocin (STZ, concentration 100 mg/ml) at a dose of 30 mg/kg b.w. in citrate buffer, pH 4.5 was used. Wounds were excised by cutting a 10-mm-diameter flap of full-thickness skin with a barb under inhalation anaesthesia, 5% isoflurane under aseptic conditions. Wounds were treating with standard used preparation and with prototype product containing an alcoholic extract of Phallus impudicus. A number of metabolites which promote wound healing including amino acids, sugars, organic acids and other compounds were identified in ethanolic extract by GC-MS. In the MTT test, the alcoholic extract of P. impudicus was non-toxic and stimulated fibroblast proliferation, which was also expressed as an increase in DNA and collagen synthesis. A hydrogel containing an extract of the fungus Phallus impudicus was shown to accelerate the period of wound desquamation in the experimental animals compared to the control groups. There was also a statistically significant (p>0.005) reduction in SOD activity and in TBARS compared to the control group, indicating an intensive healing process in which the oxidative enzyme systems play a significant role.